Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;5(11):e1716.
doi: 10.1002/cnr2.1716. Epub 2022 Sep 22.

DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study

Mohammad Reza Kheyrandish  1 , Seyed Mostafa Mir  2   3 , Mehdi Sheikh Arabi  1
Affiliations
Review

DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study

Mohammad Reza Kheyrandish et al. Cancer Rep (Hoboken). 2022 Nov.

Abstract

Esophageal cancer (EC) is a common malignancy with a poor prognosis worldwide. There are two core pathways that repair double-strand breaks, homologous recombination (HR) and non-homologous end joining (NHEJ) and numerous proteins are recognized that affect the occurrence of HR and NHEJ. Altered DNA damage response (DDR) pathways are associated with cancer susceptibility and affect therapeutic response and resistance in cancers. DDR pathway alterations in EC are still poorly understood. Therefore, the identification of alterations in specific genes in DDR pathways may potentially result in novel treatments for resistant cancers, especially EC. In this review, we aimed to focus on different aspects of DNA damage and repair processes in EC. Also, we reviewed new therapeutic strategies via targeting DNA repair machinery components.

Keywords: DNA repair pathways; esophageal cancer; therapeutic strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
The graphic represents the details of the HR pathway and the factors that involved in interfering this path
FIGURE 2
FIGURE 2
The graphic represents the details of the NHEJ pathway and the factors that involved in reducing this path
See this image and copyright information in PMC

References

    1. Then EO, Michell Lopez SS, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020;11(2):55‐64. - PMC - PubMed
    1. Akagündüz DD, Türker PF. Nutritional support in older patients with esophageal cancer undergoing chemoradiotherapy. Nutrit Cancer. 2022;74(10):3634‐3639. doi:10.1080/01635581.2022.2096245 - DOI - PubMed
    1. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010‐1021. - PubMed
    1. Chiu WC, Fang PT, Lee YC, et al. DNA repair protein Rad51 induces tumor growth and metastasis in esophageal squamous cell carcinoma via a p38/Akt‐dependent pathway. Ann Surg Oncol. 2020;27(6):2090‐2101. - PubMed
    1. Keles M, Sahin I, Kurt A, et al. Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma. Afr Health Sci. 2019;19(1):1671‐1676. - PMC - PubMed

Publication types